The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.

NEW YORK — MDxHealth on Wednesday posted a 22 percent year-over-year increase in its first quarter revenues, topping Wall Street's consensus estimate. For the three-month period ended March 31, ...

Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke patients in the UK, Europe, and US.

EsoGuard esophageal precancer testing volume rose 25 percent to 3,034 tests in the first quarter compared to 2,420 tests in Q1 2024.

Kuppusamy noted that Quest does offer testing, and advanced diagnostic testing in particular, through its Global Diagnostics ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK - Teal Health announced Friday that its self-collection device for human papillomavirus testing has obtained US Food and Drug Administration approval. The device can be used to collect ...

NEW YORK – Although it had multiple products with regulatory clearance and technology that had been validated by outside users, Accelerate Diagnostics' inability to attract buyers for its instruments ...

Congress has passed delays to PAMA implementation, but such a pause could be less likely this year, warn industry stakeholders.